Skip to main content
Journal cover image

Post-tuberculosis lung disease: towards prevention, diagnosis, and care.

Publication ,  Journal Article
Meghji, J; Auld, SC; Bisson, GP; Khosa, C; Masekela, R; Navuluri, N; Rachow, A
Published in: Lancet Respir Med
May 2025

There is a growing body of data describing the high burden of respiratory sequelae seen among tuberculosis survivors, including children, adolescents, and adults. This group of sequelae are known as post-tuberculosis lung disease and include parenchymal damage, airway disease, and pulmonary vascular disease. It is thought that approximately half of pulmonary tuberculosis survivors have ongoing structural pathology, lung function impairment, or respiratory symptoms after the resolution of active disease. Post-tuberculosis lung disease has been associated with adverse patient outcomes, including persistent symptoms and functional impairment, ongoing health seeking, and impacts on income and employment. There is still much to understand about the epidemiology and nature of post-tuberculosis lung disease, but in this Review we focus on strategies for prevention, diagnosis, and care to inform the ongoing work of tuberculosis-affected communities, health-care providers, researchers, and policy makers. We summarise recent data, highlight evidence gaps, and suggest key research priorities for those working in the field.

Duke Scholars

Published In

Lancet Respir Med

DOI

EISSN

2213-2619

Publication Date

May 2025

Volume

13

Issue

5

Start / End Page

460 / 472

Location

England

Related Subject Headings

  • Tuberculosis, Pulmonary
  • Survivors
  • Lung Diseases
  • Humans
  • Child
  • Adult
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1199 Other Medical and Health Sciences
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Meghji, J., Auld, S. C., Bisson, G. P., Khosa, C., Masekela, R., Navuluri, N., & Rachow, A. (2025). Post-tuberculosis lung disease: towards prevention, diagnosis, and care. Lancet Respir Med, 13(5), 460–472. https://doi.org/10.1016/S2213-2600(24)00429-6
Meghji, Jamilah, Sara C. Auld, Gregory P. Bisson, Celso Khosa, Refiloe Masekela, Neelima Navuluri, and Andrea Rachow. “Post-tuberculosis lung disease: towards prevention, diagnosis, and care.Lancet Respir Med 13, no. 5 (May 2025): 460–72. https://doi.org/10.1016/S2213-2600(24)00429-6.
Meghji J, Auld SC, Bisson GP, Khosa C, Masekela R, Navuluri N, et al. Post-tuberculosis lung disease: towards prevention, diagnosis, and care. Lancet Respir Med. 2025 May;13(5):460–72.
Meghji, Jamilah, et al. “Post-tuberculosis lung disease: towards prevention, diagnosis, and care.Lancet Respir Med, vol. 13, no. 5, May 2025, pp. 460–72. Pubmed, doi:10.1016/S2213-2600(24)00429-6.
Meghji J, Auld SC, Bisson GP, Khosa C, Masekela R, Navuluri N, Rachow A. Post-tuberculosis lung disease: towards prevention, diagnosis, and care. Lancet Respir Med. 2025 May;13(5):460–472.
Journal cover image

Published In

Lancet Respir Med

DOI

EISSN

2213-2619

Publication Date

May 2025

Volume

13

Issue

5

Start / End Page

460 / 472

Location

England

Related Subject Headings

  • Tuberculosis, Pulmonary
  • Survivors
  • Lung Diseases
  • Humans
  • Child
  • Adult
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1199 Other Medical and Health Sciences
  • 1117 Public Health and Health Services